Bear....Is this why SGLT2 inhibitors synergized so well with ABL in the BOM trial ?
"It's passé to think of the sodium-glucose cotransporter 2 (SGLT2) inhibitor drugs as agents that primarily treat hyperglycemia because their major clinical role has rapidly morphed into treating or preventing heart failure and chronic kidney disease."
